Abstract

BackgroundTofacitinib (CP-690,550) is a novel, oral Janus kinase inhibitor being investigated as a targeted immunomodulator in rheumatoid arthritis.ObjectivesTo assess efficacy of tofacitinib 5 and 10 mg twice-daily (BID) using disease...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
AB0436 Comparison of tofacitinib efficacy in patients with moderate vs severe rheumatoid arthritis: pooled analysis of phase 3 studies
S Schwartzman ... M Snyder
Annals of the Rheumatic Diseases | VOL. 76
S Schwartzman, et. al.S Schwartzman ... M Snyder
01 Jun 2017
SAT0111 Efficacy of tofacitinib in patients with moderate to severe rheumatoid arthritis by baseline c-reactive protein levels and erythrocyte sedimentation rates
S Schwartzman ... H Fan
Annals of the Rheumatic Diseases | VOL. 77
S Schwartzman, et. al.S Schwartzman ... H Fan
01 Jun 2018
FRI0110 Assessment of Immunogenicity of Live Zoster Vaccination in Rheumatoid Arthritis Patients on Background Methotrexate before and after Initiating Tofacitinib or Placebo
K Winthrop ... K Soma
Annals of the Rheumatic Diseases | VOL. 75
K Winthrop, et. al.K Winthrop ... K Soma
01 Jun 2016
AB0921 Impact of baseline demographics, disease activity and concomitant medication on american college of rheumatology 20 response rate and health assessment questionnaire-disability index score with tofacitinib in active psoriatic arthritis: a pooled subgroup analysis of 2 phase 3 studies
F Behrens ... C Wang
Annals of the Rheumatic Diseases | VOL. 77
F Behrens, et. al.F Behrens ... C Wang
01 Jun 2018
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here?
Daniel J Clauw
Annals of the Rheumatic Diseases | VOL. -
Daniel J ClauwDaniel J Clauw
06 Aug 2024
Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS–SPARTAN collaboration
Robert G W Lambert ... Walter P Maksymowych
Annals of the Rheumatic Diseases | VOL. -
Robert G W Lambert, et. al.Robert G W Lambert ... Walter P Maksymowych
06 Aug 2024
Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseases
Ann-Kathrin Eiers ... Jan P Tuckermann
Annals of the Rheumatic Diseases | VOL. -
Ann-Kathrin Eiers, et. al.Ann-Kathrin Eiers ... Jan P Tuckermann
06 Aug 2024
Helicobacter pylori upregulates PAD4 expression via stabilising HIF-1α to exacerbate rheumatoid arthritis
Hui Wu ... Chao Wu
Annals of the Rheumatic Diseases | VOL. -
Hui Wu, et. al.Hui Wu ... Chao Wu
06 Aug 2024
View more papers